View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. Theme
  2. Macro
  3. Covid-19
June 29, 2020

How to stand out from the crowd: What Big Pharma looks for when acquiring

By Victoria Smith

Specialists in the Pharmaceutical deal-making scope met virtually for the 2020 BIO International Convention last week to discuss the topic of ‘How to Get Acquired: What Companies Look for When in Acquisition Mode,’ including how Covid-19 has radically changed how companies function, with insight on innovative Biotechs looking to be procured by Big Pharma.

The panellists agreed that pre-Covid-19, Big Pharma preferred to acquire an asset pre-launch. Read more here.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Pharmaceutical Technology